Maravai LifeSciences 8-K Report: Key Updates on December 18, 2024

Based on the provided section of the financial report, here are the key pieces of information extracted:

Company Information:

Name: Maravai LifeSciences Holdings, Inc.
CIK: 0001823239
SEC File Number: 001-39725
EIN: 85-2786970
Address: 10770 Wateridge Circle Suite 200, San Diego, CA 92121
Phone Number: 858-546-0004

Filing Type:

Form: 8-K
Filing Date: December 18, 2024

Security Information:

Class of Stock: Class A Common Stock
Par Value: $0.01
Ticker Symbol: MRVI
Exchange: NASDAQ

Reporting Period:

Start Date: December 18, 2024
End Date: December 18, 2024

XML and XBRL Metadata:

The report is encoded in XML format and utilizes XBRL (eXtensible Business Reporting Language) for structured financial reporting.

Insights:

Maravai LifeSciences is filing an 8-K, which typically indicates that the company is reporting significant events or changes that shareholders should be aware of.
The filing is dated for a singular day, suggesting that it may pertain to a specific event occurring on that date, such as an earnings announcement, board meeting outcome, or other major corporate actions.
The company is publicly traded under the ticker MRVI on NASDAQ, which indicates it is subject to SEC regulations and reporting requirements.

This information is crucial for investors, analysts, and stakeholders to understand the company's current reporting status and any significant developments associated with it.